| # | Side effect | Count |
|---|---|---|
| 0 | MUSCLE SPASMS | 230 |
| 1 | ALOPECIA | 136 |
| 2 | FATIGUE | 123 |
| 3 | DEATH | 119 |
| 4 | OFF LABEL USE | 117 |
| 5 | PRODUCT USE ISSUE | 96 |
| 6 | NAUSEA | 90 |
| 7 | PRODUCT DOSE OMISSION ISSUE | 89 |
| 8 | AGEUSIA | 82 |
| 9 | THERAPY CESSATION | 82 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | LEUCINE AMINOPEPTIDASE DECREASED | 1 | 0.3333 |
| 1 | RHINOSCLEROMA | 2 | 0.2222 |
| 2 | POSITIVE DOSE RESPONSE RELATIONSHIP | 1 | 0.1429 |
| 3 | APOLIPOPROTEIN A-I INCREASED | 1 | 0.1111 |
| 4 | APOLIPOPROTEIN INCREASED | 1 | 0.1000 |
| 5 | SQUAMOUS CELL CARCINOMA OF THE PAROTID GLAND | 1 | 0.0526 |
| 6 | MALIGNANT RENAL HYPERTENSION | 1 | 0.0500 |
| 7 | BLOOD CANNABINOIDS INCREASED | 1 | 0.0417 |
| 8 | ARTERIAL GRAFT | 1 | 0.0323 |
| 9 | ORBITAL HAEMORRHAGE | 1 | 0.0323 |